Immunotherapy for HNSCC – OncLive
OncLive |
Immunotherapy for HNSCC
OncLive Ezra Cohen, MD: Of course, we're now moving into a new era of immunotherapy, something that we've all been excited about, first with preliminary phase I data and now with larger data sets. Barbara, we've got, for the first time in a little while, new … |
